Skyrizi

  • Brand name/Generic name: Skyrizi/risankizumab-rzaa
  • How Administered at HOA:
    • subcutaneous injection for psoriasis and ulcerative colitis
    • intravenous infusion for Crohn’s disease
  • Duration of Treatment:
    • one hour for Crohn’s disease
    • two hours for ulcerative colitis
  • Frequency of Treatment: every four weeks
  • Conditions this Medication Treats:
    • Plaque psoriasis
    • Psoriatic arthritis
    • Crohn disease
    • Ulcerative colitis
  • Link for more Information: https://www.skyrizi.com/
Main Image: